Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The PATH Malaria Vaccine Initiative (MVI) | OTHER |
The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).
This study is a multicenter epidemiology study at centers that are participating in GSK's pivotal Phase III candidate malaria vaccine 110021 ( NCT00866619) trial and will involve 4 annual cross sectional surveys performed preferably at peak transmission.
There will be no study vaccine administered in this epidemiology study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Overall Study Group (Survey 1) | Experimental | Subjects at least 6 months of age at the time of Survey 1, conducted at Year 1 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
|
| Overall Study Group (Survey 2) | Experimental | Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
|
| Overall Study Group (Survey 3) | Experimental | Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood sampling | Procedure | Capillary blood samples collected by finger/heel prick |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), for Each Survey | The Overall parasite prevalence (PP) data were collected across centers from subjects aged between and including: 6 months to 4 Years (6M-4Y), 5 to 19 Years (5-19 Y) and 20 Years or older (20Y+), for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated. | At each Survey visit |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), According to Annual Age for Children of 4 Years or Less, for Each Survey | The overall parasite prevalence (PP) data were collected across centers from subjects aged 4 years or less, for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Ouagadougou | Burkina Faso | ||||
| GSK Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29078773 | Background | Drakeley C, Abdulla S, Agnandji ST, Fernandes JF, Kremsner P, Lell B, Mewono L, Bache BE, Mihayo MG, Juma O, Tanner M, Tahita MC, Tinto H, Diallo S, Lompo P, D'Alessandro U, Ogutu B, Otieno L, Otieno S, Otieno W, Oyieko J, Asante KP, Dery DB, Adjei G, Adeniji E, Atibilla D, Owusu-Agyei S, Greenwood B, Gesase S, Lusingu J, Mahende C, Mongi R, Segeja M, Adjei S, Agbenyega T, Agyekum A, Ansong D, Bawa JT, Boateng HO, Dandalo L, Escamilla V, Hoffman I, Maenje P, Martinson F, Carter T, Leboulleux D, Kaslow DC, Usuf E, Pircon JY, Bahmanyar ER. Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries. Malar J. 2017 Oct 27;16(1):433. doi: 10.1186/s12936-017-2078-3. |
Not provided
Not provided
IPD for this study will be made available via the Clinical Study Data Request site.
IPD is available via the Clinical Study Data Request site (click on the link provided below)
Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.
Not provided
For each year and each site, approximately 400 subjects at least 6 months and < 5 years old, approximately 200 subjects at least 5 years and < 20 years old and approximately 200 subjects at least 20 years old were to be enrolled. The study was conducted at 8 sites and 6 countries for the first 3 surveys and 3 sites from 3 countries for Survey 4.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Overall Study Group (Survey 1) | Subjects at least 6 months of age at the time of Survey 1, conducted at Year 1 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| FG001 | Overall Study Group (Survey 2) | Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| FG002 | Overall Study Group (Survey 3) | Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| FG003 | Overall Study Group (Survey 4) | Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Overall Study Group (Survey 1) | Subjects at least 6 months of age at the time of Survey 1, conducted at Year 1 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), for Each Survey | The Overall parasite prevalence (PP) data were collected across centers from subjects aged between and including: 6 months to 4 Years (6M-4Y), 5 to 19 Years (5-19 Y) and 20 Years or older (20Y+), for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At each Survey visit |
|
Capillary blood sampling was the only invasive procedure involved in this study. Serious adverse events (SAEs) related to this procedure were recorded at each survey visit.
Anticipated and unanticipated adverse events symptoms were not collected in the study.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Overall Study Group (Survey 1) | Subjects at least 6 months of age at the time of Survey 1, conducted at Year 1 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| GSK Response Center | GlaxoSmithKline | 866-435-7343 | GSKClinicalSupportHD@gsk.com |
Not provided
| ID | Term |
|---|---|
| D008288 | Malaria |
| D016778 | Malaria, Falciparum |
| ID | Term |
|---|---|
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D007239 | Infections |
| D000096724 | Mosquito-Borne Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| Overall Study Group (Survey 4) | Experimental | Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
|
| Assessment of body temperature | Procedure | Assessment of axial body temperature with a digital thermometer |
|
| At each Survey visit |
| Number of Subjects With Anemia and Severe Anemia for Each Survey | The overall anemia and severe anemia data were collected across centers from subjects, aged between and including: 6M-4Y, 5-19 Y and 20Y+, for each survey. Hemoglobin (Hgb) cut-offs used to define anemia and severe anemia in people living at sea level are: Anemia: children 6M to 5Y, Hgb lower than (<) 11 gram per deciliter (g/dL); children 5-11Y, Hgb <11.5 g/dL; children 12-13Y, Hgb <12 g/dL; non-pregnant females, Hgb <12 g/dL; pregnant females, Hgb <11 g/dL; males, Hgb <13 g/dL. Severe anemia: any age or gender, Hgb <7 g/dL. Missing/ Not applicable (NA) = if age or pregnancy status was not available. Among each age category, results for both sub-categories "Yes" (subjects with anemia) and "Missing/NA" are presented below, results for the category "No" can be deduced from the number of participants analyzed in the corresponding age category, minus (number of "Yes" + number of "Missing/NA"). Similar presentation is followed for "severe anemia" results. | During the survey period (approximatively 1 year) |
| Number of Subjects With Anti-malarial Therapy in Survey 1, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | During the survey period (approximatively 1 year) |
| Number of Subjects With Anti-malarial Therapy in Survey 2, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | During the survey period (approximatively 1 year) |
| Number of Subjects With Anti-malarial Therapy in Survey 3, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | During the survey period (approximatively 1 year) |
| Number of Subjects With Anti-malarial Therapy in Survey 4, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | During the survey period (approximatively 1 year) |
| Mean Number of Days With Malaria Treatment at Survey 1 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the 14 day-period before the malaria treatment |
| Mean Number of Days With Malaria Treatment at Survey 2 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the 14 day-period before the malaria treatment |
| Mean Number of Days With Malaria Treatment at Survey 3 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the 14 day-period before the malaria treatment |
| Mean Number of Days With Malaria Treatment at Survey 4 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the 14 day-period before the malaria treatment |
| Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 1 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | In the last 24 hours or at the survey visit |
| Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 2 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | In the last 24 hours or at the survey visit |
| Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 3 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | In the last 24 hours or at the survey visit |
| Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 4 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | In the last 24 hours or at the survey visit |
| Mean Number of Days With Fever at Survey 1 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the survey period (approximatively 1 year) |
| Mean Number of Days With Fever at Survey 2 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the survey period (approximatively 1 year) |
| Mean Number of Days With Fever at Survey 3 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the survey period (approximatively 1 year) |
| Mean Number of Days With Fever at Survey 4 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | During the survey period (approximatively 1 year) |
| Axillary Temperature at Visit in Survey 1 | The mean and standard deviation of the axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Axillary Temperature at Visit in Survey 2 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Axillary Temperature at Visit in Survey 3 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Axillary Temperature at Visit in Survey 4 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Living in the Same House at Survey 1 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Living in the Same House at Survey 2 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Living in the Same House at Survey 3 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Living in the Same House at Survey 4 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Mean Number of Subjects Living in the Same House at Survey 1 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Mean Number of Subjects Living in the Same House at Survey 2 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Mean Number of Subjects Living in the Same House at Survey 3 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Mean Number of Subjects Living in the Same House at Survey 4 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by Localisation and Type of Location at Survey 1 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural or missing) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants or missing type of location). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by Localisation and Type of Location at Survey 2 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by Localisation and Type of Location at Survey 3 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by Localisation and Type of Location at Survey 4 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 1 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other and missing. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet, missing. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 2 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 3 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 4 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 1 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other, missing. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open, missing. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 2 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 3 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 4 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 1 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water), missing; and Presence of electricity (PE): Yes, No, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 2 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 3 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 4 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | At Survey visit |
| Number of Subjects With Malaria Prevention Measures (MPM) at Each Survey | The malaria prevention measures (MPM) data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for each Survey. The MPM results include the following categories: Use of Mosquito coils over 7 days (UMc > 7D), Use of Insecticide spray over 7 days (UIs > 7D), Use of Commercial Repellents over 7 days (UCR > 7D), Use of Traditional Repellents over 7 days (UTR > 7D), Use of none of above over 7 days (Una >7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM) or Use of indoor residual spray- no spray (Uirs-no spray): the number of months ago for each Uirs-nM sub-categories is defined using the following [x Months]. Not all Uirs-nM sub-categories were analyzed in each survey. | At each Survey visit |
| Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 1 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | At Survey visit |
| Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 2 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | At Survey visit |
| Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 3 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | At Survey visit |
| Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 4 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | At Survey visit |
| Number of Subjects With Serious Adverse Events (SAEs) Related to Study Procedure for Each Survey | Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. Capillary blood sampling was the only invasive procedure involved in this study. SAEs related to this procedure were recorded at the Survey visit. | At each Survey visit |
| Lambaréné |
| Gabon |
| GSK Investigational Site | Kintampo | Ghana |
| GSK Investigational Site | Kumasi | Ghana |
| GSK Investigational Site | Kisumu | Kenya |
| GSK Investigational Site | Lilongwe | Malawi |
| GSK Investigational Site | Dar es Salaam | Tanzania |
| GSK Investigational Site | Korogwe, Tanga | Tanzania |
| BG001 | Overall Study Group (Survey 2) | Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| BG002 | Overall Study Group (Survey 3) | Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| BG003 | Overall Study Group (Survey 4) | Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| BG004 | Total | Total of all reporting groups |
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| OG001 | Overall Study Group (Survey 2) | Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| OG002 | Overall Study Group (Survey 3) | Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
| OG003 | Overall Study Group (Survey 4) | Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. |
|
|
| Secondary | Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), According to Annual Age for Children of 4 Years or Less, for Each Survey | The overall parasite prevalence (PP) data were collected across centers from subjects aged 4 years or less, for each Survey. The number of subjects P. Falciparum parasitemia infected among the number of subjects with known result for P.falciparum parasitemia test was tabulated. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At each Survey visit |
|
|
|
| Secondary | Number of Subjects With Anemia and Severe Anemia for Each Survey | The overall anemia and severe anemia data were collected across centers from subjects, aged between and including: 6M-4Y, 5-19 Y and 20Y+, for each survey. Hemoglobin (Hgb) cut-offs used to define anemia and severe anemia in people living at sea level are: Anemia: children 6M to 5Y, Hgb lower than (<) 11 gram per deciliter (g/dL); children 5-11Y, Hgb <11.5 g/dL; children 12-13Y, Hgb <12 g/dL; non-pregnant females, Hgb <12 g/dL; pregnant females, Hgb <11 g/dL; males, Hgb <13 g/dL. Severe anemia: any age or gender, Hgb <7 g/dL. Missing/ Not applicable (NA) = if age or pregnancy status was not available. Among each age category, results for both sub-categories "Yes" (subjects with anemia) and "Missing/NA" are presented below, results for the category "No" can be deduced from the number of participants analyzed in the corresponding age category, minus (number of "Yes" + number of "Missing/NA"). Similar presentation is followed for "severe anemia" results. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Number of Subjects With Anti-malarial Therapy in Survey 1, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Number of Subjects With Anti-malarial Therapy in Survey 2, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Number of Subjects With Anti-malarial Therapy in Survey 3, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Number of Subjects With Anti-malarial Therapy in Survey 4, According to Parasite Density | The overall anti-malaria therapy data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). Results include the following categories: Malaria treatment (MT) in past 14 days with sub-categories assessed: Yes, No; Exact days of malaria treatment (EDMT) with sub-categories assessed: Ongoing, 1-3 Days, ≥ 4 Days, Missing/NA; Other medication (OM) in past 14 days with sub-categories assessed: Yes, No; Days of other medication (DOM) with sub-categories assessed: Ongoing, 1-7 Days, ≥ 8 Days, Missing/NA; Malaria hospitalization (MH) in the last 3 months with sub-categories assessed: Yes, No. Missing/NA = Missing or Not Applicable.* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Mean Number of Days With Malaria Treatment at Survey 1 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and who have data available during the past 14 days period of Malaria treatment. | Posted | Mean | Standard Deviation | Days | During the 14 day-period before the malaria treatment |
|
|
|
| Secondary | Mean Number of Days With Malaria Treatment at Survey 2 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and who have data available during the past 14 days period of Malaria treatment. | Posted | Mean | Standard Deviation | Days | During the 14 day-period before the malaria treatment |
|
|
|
| Secondary | Mean Number of Days With Malaria Treatment at Survey 3 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and who have data available during the past 14 days period of Malaria treatment. | Posted | Mean | Standard Deviation | Days | During the 14 day-period before the malaria treatment |
|
|
|
| Secondary | Mean Number of Days With Malaria Treatment at Survey 4 | The mean and standard deviation of the number of days of malaria treatment (DMT) were calculated for the past 14 days period of treatment. The malaria treatment data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and who have data available during the past 14 days period of Malaria treatment. | Posted | Mean | Standard Deviation | Days | During the 14 day-period before the malaria treatment |
|
|
|
| Secondary | Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 1 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | In the last 24 hours or at the survey visit |
|
|
|
| Secondary | Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 2 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | In the last 24 hours or at the survey visit |
|
|
|
| Secondary | Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 3 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | In the last 24 hours or at the survey visit |
|
|
|
| Secondary | Number of Subjects With Fever in the Last 24 Hours or at Visit During Survey 4 | Measured characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever at visit (F at V). Note: Fever set to "Yes" if temperature recorded after axillary conversion was ≥ 37.5 degrees Celsius (°C). Missing/NA = Missing or Not Applicable. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | In the last 24 hours or at the survey visit |
|
|
|
| Secondary | Mean Number of Days With Fever at Survey 1 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and with fever reported in the last 24 hours. | Posted | Mean | Standard Deviation | Days | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Mean Number of Days With Fever at Survey 2 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and with fever reported in the last 24 hours. | Posted | Mean | Standard Deviation | Days | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Mean Number of Days With Fever at Survey 3 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and with fever reported in the last 24 hours. | Posted | Mean | Standard Deviation | Days | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Mean Number of Days With Fever at Survey 4 | The mean and standard deviation of the number of days ago with fever start (DaFs) were calculated for subjects having fever in the last 24 hours. Fever data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit and with fever reported in the last 24 hours. | Posted | Mean | Standard Deviation | Days | During the survey period (approximatively 1 year) |
|
|
|
| Secondary | Axillary Temperature at Visit in Survey 1 | The mean and standard deviation of the axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Degrees Celsius | At Survey visit |
|
|
|
| Secondary | Axillary Temperature at Visit in Survey 2 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Degrees Celsius | At Survey visit |
|
|
|
| Secondary | Axillary Temperature at Visit in Survey 3 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Degrees Celsius | At Survey visit |
|
|
|
| Secondary | Axillary Temperature at Visit in Survey 4 | The mean and standard deviation of axillary temperature at visit (A temp. at V) were calculated. Axillary temperature data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Degrees Celsius | At Survey visit |
|
|
|
| Secondary | Number of Subjects Living in the Same House at Survey 1 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Living in the Same House at Survey 2 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Living in the Same House at Survey 3 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Living in the Same House at Survey 4 | The malaria prevention and risk factors characteristics were: Number of persons living in the same part of the house (PLSPH) among persons enrolled in the study (PES), in the following combinations: < y/x (less than [<] y PLSPH among x PES), y-z/x (y to z PLSPH among x PES), > z/x (more than [>] z PLSPH among x PES), y-z/> x (y to z PLSPH among more than [>] x PES), > z/> x (more than [>] z PLSPH among more than [>] x PES, or missing information). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Mean Number of Subjects Living in the Same House at Survey 1 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Persons | At Survey visit |
|
|
|
| Secondary | Mean Number of Subjects Living in the Same House at Survey 2 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Persons | At Survey visit |
|
|
|
| Secondary | Mean Number of Subjects Living in the Same House at Survey 3 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Persons | At Survey visit |
|
|
|
| Secondary | Mean Number of Subjects Living in the Same House at Survey 4 | The malaria prevention and risk factors characteristics were the following: the mean and standard deviation of the number of persons living in the same part of the house (PLSPH). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Mean | Standard Deviation | Persons | At Survey visit |
|
|
|
| Secondary | Number of Subjects by Localisation and Type of Location at Survey 1 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural or missing) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants or missing type of location). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by Localisation and Type of Location at Survey 2 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by Localisation and Type of Location at Survey 3 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by Localisation and Type of Location at Survey 4 | The malaria prevention and risk factors characteristics were the following: localisation categories (i.e.: rural, urban, semi-rural) and Type of Location (i.e.: Large city: >1 million habitants; Small city: >50000 & < 1 million habitants; Town: > 10000 and < 50000 habitants; Countryside: < 10000 habitants). Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 1 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other and missing. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet, missing. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 2 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, parquet polished wood, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 3 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects by House Construction Material Regarding Walls and Floor at Survey 4 | The malaria prevention and risk factors characteristics were the following: Main house construction material (MHCM) walls and MHCM floor. MHCM walls data were assessed for the following sub-categories: mud, brick, cement/plaster, cement/paint, other. MHCM floor data were assessed for the following sub-categories: natural floor, rudimentary floor, vinyl or asphalt strips, ceramic tiles, cement, carpet. Note: Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 1 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other, missing. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open, missing. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 2 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 3 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, tiles, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Construction Material Regarding Roof, Window/Eaves and Nets at Survey 4 | The malaria prevention and risk factors characteristics were the following: main house construction material (MHCM) roof, windows/eaves, nets. MHCM roof data were assessed for the following sub-categories: grass/palm, iron sheet, other. MHCM windows/eaves data were assessed for the following sub-categories: closed, open, partially open. MHCM nets data were assessed for the following sub-categories: nets not present, nets present on all windows, nets present on some windows. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 1 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water), missing; and Presence of electricity (PE): Yes, No, missing. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 2 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 3 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects Classified by House Information Regarding Main Source of the Drinking Water and Presence of Electricity at Survey 4 | The malaria prevention and risk factors characteristics were the following: Main source of drinking water (MSDW): bottled water, closed water source (piped water, tube well, dug well, protected well), open water source (unprotected well, spring water, rainwater, tanker truck, surface water); and Presence of electricity (PE): Yes, No. Data were collected across centers from subjects between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. Results were presented per the following P. falciparum parasite density status subgroups: Low, Medium, High, Very high, and Negative (Neg). | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects With Malaria Prevention Measures (MPM) at Each Survey | The malaria prevention measures (MPM) data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for each Survey. The MPM results include the following categories: Use of Mosquito coils over 7 days (UMc > 7D), Use of Insecticide spray over 7 days (UIs > 7D), Use of Commercial Repellents over 7 days (UCR > 7D), Use of Traditional Repellents over 7 days (UTR > 7D), Use of none of above over 7 days (Una >7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM) or Use of indoor residual spray- no spray (Uirs-no spray): the number of months ago for each Uirs-nM sub-categories is defined using the following [x Months]. Not all Uirs-nM sub-categories were analyzed in each survey. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At each Survey visit |
|
|
|
| Secondary | Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 1 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 1. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 2 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 2. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 3 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 3. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects With Plasmodium Species Other Than P. Falciparum at Survey 4 | Data were collected across centers from subjects with age between and including: 6M-4Y, 5-19 Y and 20Y+, for Survey 4. The other Plasmodium species assessed were: P. Malaria, P. Vivax, P. Ovale. Infection were determined using a blood smear slide, and categorized according positive (Pos) and negative (Neg) results. | Analysis was performed on the According-to-Protocol (ATP) Cohort, which included all evaluable subjects for whom at least one laboratory result of blood sample was available at the survey visit. | Posted | Count of Participants | Participants | At Survey visit |
|
|
|
| Secondary | Number of Subjects With Serious Adverse Events (SAEs) Related to Study Procedure for Each Survey | Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. Capillary blood sampling was the only invasive procedure involved in this study. SAEs related to this procedure were recorded at the Survey visit. | The analysis was performed on the Total cohort, which included all subjects enrolled in the study. | Posted | Count of Participants | Participants | At each Survey visit |
|
|
|
| 0 |
| 6,404 |
| 0 |
| 6,404 |
| 0 |
| 0 |
| EG001 | Overall Study Group (Survey 2) | Subjects at least 6 months of age at the time of Survey 2, conducted at Year 2 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. | 0 | 6,414 | 0 | 6,414 | 0 | 0 |
| EG002 | Overall Study Group (Survey 3) | Subjects at least 6 months of age at the time of Survey 3, conducted at Year 3 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. | 0 | 6,400 | 0 | 6,400 | 0 | 0 |
| EG003 | Overall Study Group (Survey 4) | Subjects at least 6 months of age at the time of Survey 4, conducted at Year 4 of the 4 annual cross sectional surveys performed preferably at peak transmission (end of rainy season), infected with P. falciparum parasite. Infection determined using a blood smear slide and determined using microscopy. Subjects were enrolled from the catchment areas of study 110021 (NCT00866619) but those who previously participated in study 110021 were excluded from this epidemiological study. | 0 | 2,400 | 0 | 2,400 | 0 | 0 |
GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
| D000079426 |
| Vector Borne Diseases |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |
| Male |
|
| Title | Measurements |
|---|---|
|
| Title | Measurements |
|---|---|
|
|
| Children aged 1 year |
|
|
| Children aged 2 years |
|
|
| Children aged 3 years |
|
|
| Children aged 4 years |
|
|
|
| Missing/NA Anemia, 6M-4Y |
|
|
| Overall Yes, Anemia, 5-19Y |
|
|
| Missing/NA Anemia, 5-19Y |
|
|
| Overall Yes, Anemia, 20Y+ |
|
|
| Missing/NA Anemia, 20Y+ |
|
|
| Overall Yes, Severe anaemia, 6M-4Y |
|
|
| Missing/NA Severe anemia, 6M-4Y |
|
|
| Overall Yes, Severe anaemia, 5-19Y |
|
|
| Missing/NA Severe anemia, 5-19Y |
|
|
| Overall Yes, Severe anaemia, 20Y+ |
|
|
| Missing/NA Severe anemia, 20Y+ |
|
|
|
| 6M-4Y, MT in past 14 days, No |
|
|
| 6M-4Y, EDMT *, Ongoing |
|
|
| 6M-4Y, EDMT *, 1-3 days |
|
|
| 6M-4Y, EDMT *, ≥ 4days |
|
|
| 6M-4Y, EDMT *, Missing/Not applicable |
|
|
| 6M-4Y, OM in past 14 days, Yes |
|
|
| 6M-4Y, OM in past 14 days, No |
|
|
| 6M-4Y, DOM *, Ongoing |
|
|
| 6M-4Y, DOM *, 1-7 days |
|
|
| 6M-4Y, DOM *, ≥ 8 days |
|
|
| 6M-4Y, DOM *, Missing/Not applicable |
|
|
| 6M-4Y, MH in the last 3 months, Yes |
|
|
| 6M-4Y, MH in the last 3 months, No |
|
|
| 5-19Y, MT in past 14 days, Yes |
|
|
| 5-19Y, MT in past 14 days, No |
|
|
| 5-19Y, EDMT *, Ongoing |
|
|
| 5-19Y, EDMT *, 1-3 days |
|
|
| 5-19Y, EDMT *, ≥ 4days |
|
|
| 5-19Y, EDMT *, Missing/Not applicable |
|
|
| 5-19Y, OM in past 14 days, Yes |
|
|
| 5-19Y, OM in past 14 days, No |
|
|
| 5-19Y, DOM *, Ongoing |
|
|
| 5-19Y, DOM *, 1-7 days |
|
|
| 5-19Y, DOM *, ≥ 8 days |
|
|
| 5-19Y, DOM *, Missing/Not applicable |
|
|
| 5-19Y, MH in the last 3 months, Yes |
|
|
| 5-19Y, MH in the last 3 months, No |
|
|
| 20Y+, MT in past 14 days, Yes |
|
|
| 20Y+, MT in past 14 days, No |
|
|
| 20Y+, EDMT *, Ongoing |
|
|
| 20Y+, EDMT *, 1-3 days |
|
|
| 20Y+, EDMT *, ≥ 4days |
|
|
| 20Y+, EDMT *, Missing/Not applicable |
|
|
| 20Y+, OM in past 14 days, Yes |
|
|
| 20Y+, OM in past 14 days, No |
|
|
| 20Y+, DOM *, Ongoing |
|
|
| 20Y+, DOM *, 1-7 days |
|
|
| 20Y+, DOM *, ≥ 8 days |
|
|
| 20Y+, DOM *, Missing/Not applicable |
|
|
| 20Y+, MH in the last 3 months, Yes |
|
|
| 20Y+, MH in the last 3 months, No |
|
|
|
| 6M-4Y, MT in past 14 days, No |
|
|
| 6M-4Y, EDMT *, Ongoing |
|
|
| 6M-4Y, EDMT *, 1-3 days |
|
|
| 6M-4Y, EDMT *, ≥ 4days |
|
|
| 6M-4Y, EDMT *, Missing/NA |
|
|
| 6M-4Y, OM in past 14 days, Yes |
|
|
| 6M-4Y, OM in past 14 days, No |
|
|
| 6M-4Y, DOM *, Ongoing |
|
|
| 6M-4Y, DOM *, 1-7 days |
|
|
| 6M-4Y, DOM *, ≥ 8 days |
|
|
| 6M-4Y, DOM *, Missing/NA |
|
|
| 6M-4Y, MH in the last 3 months, Yes |
|
|
| 6M-4Y, MH in the last 3 months, No |
|
|
| 5-19Y, MT in past 14 days, Yes |
|
|
| 5-19Y, MT in past 14 days, No |
|
|
| 5-19Y, EDMT *, Ongoing |
|
|
| 5-19Y, EDMT *, 1-3 days |
|
|
| 5-19Y, EDMT *, ≥ 4days |
|
|
| 5-19Y, EDMT *, Missing/NA |
|
|
| 5-19Y, OM in past 14 days, Yes |
|
|
| 5-19Y, OM in past 14 days, No |
|
|
| 5-19Y, DOM *, Ongoing |
|
|
| 5-19Y, DOM *, 1-7 days |
|
|
| 5-19Y, DOM *, ≥ 8 days |
|
|
| 5-19Y, DOM *, Missing/NA |
|
|
| 5-19Y, MH in the last 3 months, Yes |
|
|
| 5-19Y, MH in the last 3 months, No |
|
|
| 20Y+, MT in past 14 days, Yes |
|
|
| 20Y+, MT in past 14 days, No |
|
|
| 20Y+, EDMT *, Ongoing |
|
|
| 20Y+, EDMT *, 1-3 days |
|
|
| 20Y+, EDMT *, ≥ 4days |
|
|
| 20Y+, EDMT *, Missing/NA |
|
|
| 20Y+, OM in past 14 days, Yes |
|
|
| 20Y+, OM in past 14 days, No |
|
|
| 20Y+, DOM *, Ongoing |
|
|
| 20Y+, DOM *, 1-7 days |
|
|
| 20Y+, DOM *, ≥ 8 days |
|
|
| 20Y+, DOM *, Missing/NA |
|
|
| 20Y+, MH in the last 3 months, Yes |
|
|
| 20Y+, MH in the last 3 months, No |
|
|
|
| 6M-4Y, MT in past 14 days, No |
|
|
| 6M-4Y, EDMT *, Ongoing |
|
|
| 6M-4Y, EDMT *, 1-3 days |
|
|
| 6M-4Y, EDMT *, ≥ 4days |
|
|
| 6M-4Y, EDMT *, Missing/NA |
|
|
| 6M-4Y, OM in past 14 days, Yes |
|
|
| 6M-4Y, OM in past 14 days, No |
|
|
| 6M-4Y, DOM *, Ongoing |
|
|
| 6M-4Y, DOM *, 1-7 days |
|
|
| 6M-4Y, DOM *, ≥ 8 days |
|
|
| 6M-4Y, DOM *, Missing/NA |
|
|
| 6M-4Y, MH in the last 3 months, Yes |
|
|
| 6M-4Y, MH in the last 3 months, No |
|
|
| 5-19Y, MT in past 14 days, Yes |
|
|
| 5-19Y, MT in past 14 days, No |
|
|
| 5-19Y, EDMT *, Ongoing |
|
|
| 5-19Y, EDMT *, 1-3 days |
|
|
| 5-19Y, EDMT *, ≥ 4days |
|
|
| 5-19Y, EDMT *, Missing/NA |
|
|
| 5-19Y, OM in past 14 days, Yes |
|
|
| 5-19Y, OM in past 14 days, No |
|
|
| 5-19Y, DOM *, Ongoing |
|
|
| 5-19Y, DOM *, 1-7 days |
|
|
| 5-19Y, DOM *, ≥ 8 days |
|
|
| 5-19Y, DOM *, Missing/NA |
|
|
| 5-19Y, MH in the last 3 months, Yes |
|
|
| 5-19Y, MH in the last 3 months, No |
|
|
| 20Y+, MT in past 14 days, Yes |
|
|
| 20Y+, MT in past 14 days, No |
|
|
| 20Y+, EDMT *, Ongoing |
|
|
| 20Y+, EDMT *, 1-3 days |
|
|
| 20Y+, EDMT *, ≥ 4days |
|
|
| 20Y+, EDMT *, Missing/NA |
|
|
| 20Y+, OM in past 14 days, Yes |
|
|
| 20Y+, OM in past 14 days, No |
|
|
| 20Y+, DOM *, Ongoing |
|
|
| 20Y+, DOM *, 1-7 days |
|
|
| 20Y+, DOM *, ≥ 8 days |
|
|
| 20Y+, DOM *, Missing/NA |
|
|
| 20Y+, MH in the last 3 months, Yes |
|
|
| 20Y+, MH in the last 3 months, No |
|
|
|
| 6M-4Y, MT in past 14 days, No |
|
|
| 6M-4Y, EDMT *, Ongoing |
|
|
| 6M-4Y, EDMT *, 1-3 days |
|
|
| 6M-4Y, EDMT *, ≥ 4days |
|
|
| 6M-4Y, EDMT *, Missing/NA |
|
|
| 6M-4Y, OM in past 14 days, Yes |
|
|
| 6M-4Y, OM in past 14 days, No |
|
|
| 6M-4Y, DOM *, Ongoing |
|
|
| 6M-4Y, DOM *, 1-7 days |
|
|
| 6M-4Y, DOM *, ≥ 8 days |
|
|
| 6M-4Y, DOM *, Missing/NA |
|
|
| 6M-4Y, MH in the last 3 months, Yes |
|
|
| 6M-4Y, MH in the last 3 months, No |
|
|
| 5-19Y, MT in past 14 days, Yes |
|
|
| 5-19Y, MT in past 14 days, No |
|
|
| 5-19Y, EDMT *, Ongoing |
|
|
| 5-19Y, EDMT *, 1-3 days |
|
|
| 5-19Y, EDMT *, ≥ 4days |
|
|
| 5-19Y, EDMT *, Missing/NA |
|
|
| 5-19Y, OM in past 14 days, Yes |
|
|
| 5-19Y, OM in past 14 days, No |
|
|
| 5-19Y, DOM *, Ongoing |
|
|
| 5-19Y, DOM *, 1-7 days |
|
|
| 5-19Y, DOM *, ≥ 8 days |
|
|
| 5-19Y, DOM *, Missing/NA |
|
|
| 5-19Y, MH in the last 3 months, Yes |
|
|
| 5-19Y, MH in the last 3 months, No |
|
|
| 20Y+, MT in past 14 days, Yes |
|
|
| 20Y+, MT in past 14 days, No |
|
|
| 20Y+, EDMT *, Ongoing |
|
|
| 20Y+, EDMT *, 1-3 days |
|
|
| 20Y+, EDMT *, ≥ 4days |
|
|
| 20Y+, EDMT *, Missing/NA |
|
|
| 20Y+, OM in past 14 days, Yes |
|
|
| 20Y+, OM in past 14 days, No |
|
|
| 20Y+, DOM *, Ongoing |
|
|
| 20Y+, DOM *, 1-7 days |
|
|
| 20Y+, DOM *, ≥ 8 days |
|
|
| 20Y+, DOM *, Missing/NA |
|
|
| 20Y+, MH in the last 3 months, Yes |
|
|
| 20Y+, MH in the last 3 months, No |
|
|
|
| 5-19Y, DMT |
|
|
| 20+Y, DMT |
|
|
|
| 5-19Y, DMT |
|
|
| 20+Y, DMT |
|
|
|
| 5-19Y, DMT |
|
|
| 20+Y, DMT |
|
|
|
| 5-19Y, DMT |
|
|
| 20+Y, DMT |
|
|
|
| 6M-4Y, F 24h - No |
|
|
| 6M-4Y, F at V - Yes |
|
|
| 6M-4Y, F at V - No |
|
|
| 6M-4Y, F at V - Missing/NA |
|
|
| 5-19Y, F 24h - Yes |
|
|
| 5-19Y, F 24h - No |
|
|
| 5-19Y, F at V - Yes |
|
|
| 5-19Y, F at V - No |
|
|
| 20+Y, F 24h - Yes |
|
|
| 20+Y, F 24h - No |
|
|
| 20+Y, F at V - Yes |
|
|
| 20+Y, F at V - No |
|
|
| 20+Y, F at V - Missing/NA |
|
|
|
| 6M-4Y, F 24h - No |
|
|
| 6M-4Y, F at V - Yes |
|
|
| 6M-4Y, F at V - No |
|
|
| 5-19Y, F 24h - Yes |
|
|
| 5-19Y, F 24h - No |
|
|
| 5-19Y, F at V - Yes |
|
|
| 5-19Y, F at V - No |
|
|
| 20+Y, F 24h - Yes |
|
|
| 20+Y, F 24h - No |
|
|
| 20+Y, F at V - Yes |
|
|
| 20+Y, F at V - No |
|
|
| 20+Y, F at V - Missing/NA |
|
|
|
| 6M-4Y, F 24h - No |
|
|
| 6M-4Y, F at V - Yes |
|
|
| 6M-4Y, F at V - No |
|
|
| 5-19Y, F 24h - Yes |
|
|
| 5-19Y, F 24h - No |
|
|
| 5-19Y, F at V - Yes |
|
|
| 5-19Y, F at V - No |
|
|
| 5-19Y, F at V - Missing/NA |
|
|
| 20+Y, F 24h - Yes |
|
|
| 20+Y, F 24h - No |
|
|
| 20+Y, F at V - Yes |
|
|
| 20+Y, F at V - No |
|
|
| 20+Y, F at V - Missing/NA |
|
|
|
| 6M-4Y, F 24h - No |
|
|
| 6M-4Y, F at V - Yes |
|
|
| 6M-4Y, F at V - No |
|
|
| 6M-4Y, F at V - Missing/NA |
|
|
| 5-19Y, F 24h - Yes |
|
|
| 5-19Y, F 24h - No |
|
|
| 5-19Y, F at V - Yes |
|
|
| 5-19Y, F at V - No |
|
|
| 20+Y, F 24h - Yes |
|
|
| 20+Y, F 24h - No |
|
|
| 20+Y, F at V - Yes |
|
|
| 20+Y, F at V - No |
|
|
|
| 5-19Y, DaFs |
|
|
| 20+Y, DaFs |
|
|
|
| 5-19Y, DaFs |
|
|
| 20+Y, DaFs |
|
|
|
| 5-19Y, DaFs |
|
|
| 20+Y, DaFs |
|
|
|
| 5-19Y, DaFs |
|
|
| 20+Y, DaFs |
|
|
|
| 5-19Y, A temp. at V |
|
|
| 20+Y, A temp. at V |
|
|
|
| 5-19Y, A temp. at V |
|
|
| 20+Y, A temp. at V |
|
|
|
| 5-19Y, A temp. at V |
|
|
| 20+Y, A temp. at V |
|
|
|
| 5-19Y, A temp. at V |
|
|
| 20+Y, A temp. at V |
|
|
|
| 6M-4Y, PLSPH/PES, 4-5/1 |
|
|
| 6M-4Y, PLSPH/PES, >5/1 |
|
|
| 6M-4Y, PLSPH/PES, <3/2 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/2 |
|
|
| 6M-4Y, PLSPH/PES, >5/2 |
|
|
| 6M-4Y, PLSPH/PES, <3/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/3 |
|
|
| 6M-4Y, PLSPH/PES, >5/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/>3 |
|
|
| 6M-4Y, PLSPH/PES, >5/>3 |
|
|
| 6M-4Y, Missing |
|
|
| 5-19Y, PLSPH/PES, <3/1 |
|
|
| 5-19Y, PLSPH/PES, 4-5/1 |
|
|
| 5-19Y, PLSPH/PES, >5/1 |
|
|
| 5-19Y, PLSPH/PES, <3/2 |
|
|
| 5-19Y, PLSPH/PES, 4-5/2 |
|
|
| 5-19Y, PLSPH/PES, >5/2 |
|
|
| 5-19Y, PLSPH/PES, <3/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/3 |
|
|
| 5-19Y, PLSPH/PES, >5/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/>3 |
|
|
| 5-19Y, PLSPH/PES, >5/>3 |
|
|
| 5-19Y, Missing |
|
|
| 20+Y, PLSPH/PES, <3/1 |
|
|
| 20+Y, PLSPH/PES, 4-5/1 |
|
|
| 20+Y, PLSPH/PES, >5/1 |
|
|
| 20+Y, PLSPH/PES, <3/2 |
|
|
| 20+Y, PLSPH/PES, 4-5/2 |
|
|
| 20+Y, PLSPH/PES, >5/2 |
|
|
| 20+Y, PLSPH/PES, <3/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/3 |
|
|
| 20+Y, PLSPH/PES, >5/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/>3 |
|
|
| 20+Y, PLSPH/PES, >5/>3 |
|
|
| 20+Y, Missing |
|
|
|
| 6M-4Y, PLSPH/PES, 4-5/1 |
|
|
| 6M-4Y, PLSPH/PES, >5/1 |
|
|
| 6M-4Y, PLSPH/PES, <3/2 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/2 |
|
|
| 6M-4Y, PLSPH/PES, >5/2 |
|
|
| 6M-4Y, PLSPH/PES, <3/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/3 |
|
|
| 6M-4Y, PLSPH/PES, >5/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/>3 |
|
|
| 6M-4Y, PLSPH/PES, >5/>3 |
|
|
| 5-19Y, PLSPH/PES, <3/1 |
|
|
| 5-19Y, PLSPH/PES, 4-5/1 |
|
|
| 5-19Y, PLSPH/PES, >5/1 |
|
|
| 5-19Y, PLSPH/PES, <3/2 |
|
|
| 5-19Y, PLSPH/PES, 4-5/2 |
|
|
| 5-19Y, PLSPH/PES, >5/2 |
|
|
| 5-19Y, PLSPH/PES, <3/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/3 |
|
|
| 5-19Y, PLSPH/PES, >5/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/>3 |
|
|
| 5-19Y, PLSPH/PES, >5/>3 |
|
|
| 20+Y, PLSPH-PES, <3/1 |
|
|
| 20+Y, PLSPH/PES, 4-5/1 |
|
|
| 20+Y, PLSPH/PES, >5/1 |
|
|
| 20+Y, PLSPH/PES, <3/2 |
|
|
| 20+Y, PLSPH/PES, 4-5/2 |
|
|
| 20+Y, PLSPH/PES, >5/2 |
|
|
| 20+Y, PLSPH/PES, <3/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/3 |
|
|
| 20+Y, PLSPH/PES, >5/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/>3 |
|
|
| 20+Y, PLSPH/PES, >5/>3 |
|
|
|
| 6M-4Y, PLSPH/PES, 4-5/1 |
|
|
| 6M-4Y, PLSPH/PES, >5/1 |
|
|
| 6M-4Y, PLSPH/PES, <3/2 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/2 |
|
|
| 6M-4Y, PLSPH/PES, >5/2 |
|
|
| 6M-4Y, PLSPH/PES, <3/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/3 |
|
|
| 6M-4Y, PLSPH/PES, >5/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/>3 |
|
|
| 6M-4Y, PLSPH/PES, >5/>3 |
|
|
| 5-19Y, PLSPH/PES, <3/1 |
|
|
| 5-19Y, PLSPH/PES, 4-5/1 |
|
|
| 5-19Y, PLSPH/PES, >5/1 |
|
|
| 5-19Y, PLSPH/PES, <3/2 |
|
|
| 5-19Y, PLSPH/PES, 4-5/2 |
|
|
| 5-19Y, PLSPH/PES, >5/2 |
|
|
| 5-19Y, PLSPH/PES, <3/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/3 |
|
|
| 5-19Y, PLSPH/PES, >5/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/>3 |
|
|
| 5-19Y, PLSPH/PES, >5/>3 |
|
|
| 20+Y, PLSPH/PES, <3/1 |
|
|
| 20+Y, PLSPH/PES, 4-5/1 |
|
|
| 20+Y, PLSPH/PES, >5/1 |
|
|
| 20+Y, PLSPH/PES, <3/2 |
|
|
| 20+Y, PLSPH/PES, 4-5/2 |
|
|
| 20+Y, PLSPH/PES, >5/2 |
|
|
| 20+Y, PLSPH/PES, <3/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/3 |
|
|
| 20+Y, PLSPH/PES, >5/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/>3 |
|
|
| 20+Y, PLSPH/PES, >5/>3 |
|
|
|
| 6M-4Y, PLSPH/PES, 4-5/1 |
|
|
| 6M-4Y, PLSPH/PES, >5/1 |
|
|
| 6M-4Y, PLSPH/PES, <3/2 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/2 |
|
|
| 6M-4Y, PLSPH/PES, >5/2 |
|
|
| 6M-4Y, PLSPH-PES, <3/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/3 |
|
|
| 6M-4Y, PLSPH/PES, >5/3 |
|
|
| 6M-4Y, PLSPH/PES, 4-5/>3 |
|
|
| 6M-4Y, PLSPH/PES, >5/>3 |
|
|
| 5-19Y, PLSPH/PES, <3/1 |
|
|
| 5-19Y, PLSPH/PES, 4-5/1 |
|
|
| 5-19Y, PLSPH/PES, >5/1 |
|
|
| 5-19Y, PLSPH/PES, <3/2 |
|
|
| 5-19Y, PLSPH/PES, 4-5/2 |
|
|
| 5-19Y, PLSPH/PES, >5/2 |
|
|
| 5-19Y, PLSPH/PES, <3/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/3 |
|
|
| 5-19Y, PLSPH/PES, >5/3 |
|
|
| 5-19Y, PLSPH/PES, 4-5/>3 |
|
|
| 5-19Y, PLSPH/PES, >5/>3 |
|
|
| 20+Y, PLSPH/PES, <3/1 |
|
|
| 20+Y, PLSPH/PES, 4-5/1 |
|
|
| 20+Y, PLSPH/PES, >5/1 |
|
|
| 20+Y, PLSPH/PES, <3/2 |
|
|
| 20+Y, PLSPH/PES, 4-5/2 |
|
|
| 20+Y, PLSPH/PES, >5/2 |
|
|
| 20+Y, PLSPH/PES, <3/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/3 |
|
|
| 20+Y, PLSPH/PES, >5/3 |
|
|
| 20+Y, PLSPH/PES, 4-5/>3 |
|
|
| 20+Y, PLSPH/PES, >5/>3 |
|
|
|
| 5-19Y, PLSPH |
|
|
| 20+Y, PLSPH |
|
|
|
| 5-19Y, PLSPH |
|
|
| 20+Y, PLSPH |
|
|
|
| 5-19Y, PLSPH |
|
|
| 20+Y, PLSPH |
|
|
|
| 5-19Y, PLSPH |
|
|
| 20+Y, PLSPH |
|
|
|
| 6M-4Y, urban |
|
|
| 6M-4Y, semi-rural |
|
|
| 6M-4Y, missing - localisation |
|
|
| 6M-4Y, large city |
|
|
| 6M-4Y, small city |
|
|
| 6M-4Y, town |
|
|
| 6M-4Y, countryside |
|
|
| 5-19Y, rural |
|
|
| 5-19Y, urban |
|
|
| 5-19Y, semi-rural |
|
|
| 5-19Y, missing - localisation |
|
|
| 5-19Y, large city |
|
|
| 5-19Y, small city |
|
|
| 5-19Y, town |
|
|
| 5-19Y, countryside |
|
|
| 5-19Y, missing - type of localisation |
|
|
| 20+Y, rural |
|
|
| 20+Y, urban |
|
|
| 20+Y, semi-rural |
|
|
| 20+Y, missing - localisation |
|
|
| 20+Y, large city |
|
|
| 20+Y, small city |
|
|
| 20+Y, town |
|
|
| 20+Y, countryside |
|
|
| 20+Y, missing - type of localisation |
|
|
|
| 6M-4Y, urban |
|
|
| 6M-4Y, semi-rural |
|
|
| 6M-4Y, large city |
|
|
| 6M-4Y, small city |
|
|
| 6M-4Y, town |
|
|
| 6M-4Y, countryside |
|
|
| 5-19Y, rural |
|
|
| 5-19Y, urban |
|
|
| 5-19Y, semi-rural |
|
|
| 5-19Y, large city |
|
|
| 5-19Y, small city |
|
|
| 5-19Y, town |
|
|
| 5-19Y, countryside |
|
|
| 20+Y, rural |
|
|
| 20+Y, urban |
|
|
| 20+Y, semi-rural |
|
|
| 20+Y, large city |
|
|
| 20+Y, small city |
|
|
| 20+Y, town |
|
|
| 20+Y, countryside |
|
|
|
| 6M-4Y, urban |
|
|
| 6M-4Y, semi-rural |
|
|
| 6M-4Y, large city |
|
|
| 6M-4Y, small city |
|
|
| 6M-4Y, town |
|
|
| 6M-4Y, countryside |
|
|
| 5-19Y, rural |
|
|
| 5-19Y, urban |
|
|
| 5-19Y, semi-rural |
|
|
| 5-19Y, large city |
|
|
| 5-19Y, small city |
|
|
| 5-19Y, town |
|
|
| 5-19Y, countryside |
|
|
| 20+Y, rural |
|
|
| 20+Y, urban |
|
|
| 20+Y, semi-rural |
|
|
| 20+Y, large city |
|
|
| 20+Y, small city |
|
|
| 20+Y, town |
|
|
| 20+Y, countryside |
|
|
|
| 6M-4Y, urban |
|
|
| 6M-4Y, semi-rural |
|
|
| 6M-4Y, large city |
|
|
| 6M-4Y, small city |
|
|
| 6M-4Y, town |
|
|
| 6M-4Y, countryside |
|
|
| 5-19Y, rural |
|
|
| 5-19Y, urban |
|
|
| 5-19Y, semi-rural |
|
|
| 5-19Y, large city |
|
|
| 5-19Y, small city |
|
|
| 5-19Y, town |
|
|
| 5-19Y, countryside |
|
|
| 20+Y, rural |
|
|
| 20+Y, urban |
|
|
| 20+Y, semi-rural |
|
|
| 20+Y, large city |
|
|
| 20+Y, small city |
|
|
| 20+Y, town |
|
|
| 20+Y, countryside |
|
|
|
| 6M-4Y, MHCM walls - brick |
|
|
| 6M-4Y, MHCM walls - cement/plaster |
|
|
| 6M-4Y, MHCM walls - cement/paint |
|
|
| 6M-4Y, MHCM walls - other |
|
|
| 6M-4Y, MHCM floor - natural floor |
|
|
| 6M-4Y, MHCM floor - rudimentary floor |
|
|
| 6M-4Y, MHCM floor - parquet polished wood |
|
|
| 6M-4Y, MHCM floor - vinyl/asphalt strips |
|
|
| 6M-4Y, MHCM floor - ceramic tiles |
|
|
| 6M-4Y, MHCM floor - cement |
|
|
| 6M-4Y, MHCM floor - carpet |
|
|
| 5-19Y, MHCM walls - mud |
|
|
| 5-19Y, MHCM walls - brick |
|
|
| 5-19Y, MHCM walls - cement/plaster |
|
|
| 5-19Y, MHCM walls - cement/paint |
|
|
| 5-19Y, MHCM walls - other |
|
|
| 5-19Y, MHCM walls - missing |
|
|
| 5-19Y, MHCM floor - natural floor |
|
|
| 5-19Y, MHCM floor - rudimentary floor |
|
|
| 5-19Y, MHCM floor - parquet polished wood |
|
|
| 5-19Y, MHCM floor - vinyl/asphalt strips |
|
|
| 5-19Y, MHCM floor - ceramic tiles |
|
|
| 5-19Y, MHCM floor - cement |
|
|
| 5-19Y, MHCM floor - carpet |
|
|
| 5-19Y, MHCM floor - missing |
|
|
| 20+Y, MHCM walls - mud |
|
|
| 20+Y, MHCM walls - brick |
|
|
| 20+Y, MHCM walls - cement/plaster |
|
|
| 20+Y, MHCM walls - cement/paint |
|
|
| 20+Y, MHCM walls - other |
|
|
| 20+Y, MHCM walls - missing |
|
|
| 20+Y, MHCM floor - natural floor |
|
|
| 20+Y, MHCM floor - rudimentary floor |
|
|
| 20+Y, MHCM floor - parquet polished wood |
|
|
| 20+Y, MHCM floor - vinyl/asphalt strips |
|
|
| 20+Y, MHCM floor - ceramic tiles |
|
|
| 20+Y, MHCM floor - cement |
|
|
| 20+Y, MHCM floor - carpet |
|
|
| 20+Y, MHCM floor - missing |
|
|
|
| 6M-4Y, MHCM walls - brick |
|
|
| 6M-4Y, MHCM walls - cement/plaster |
|
|
| 6M-4Y, MHCM walls - cement/paint |
|
|
| 6M-4Y, MHCM walls - other |
|
|
| 6M-4Y, MHCM floor - natural floor |
|
|
| 6M-4Y, MHCM floor - rudimentary floor |
|
|
| 6M-4Y, MHCM floor - parquet polished wood |
|
|
| 6M-4Y, MHCM floor - vinyl/asphalt strips |
|
|
| 6M-4Y, MHCM floor - ceramic tiles |
|
|
| 6M-4Y, MHCM floor - cement |
|
|
| 6M-4Y, MHCM floor - carpet |
|
|
| 5-19Y, MHCM walls - mud |
|
|
| 5-19Y, MHCM walls - brick |
|
|
| 5-19Y, MHCM walls - cement/plaster |
|
|
| 5-19Y, MHCM walls - cement/paint |
|
|
| 5-19Y, MHCM walls - other |
|
|
| 5-19Y, MHCM floor - natural floor |
|
|
| 5-19Y, MHCM floor - rudimentary floor |
|
|
| 5-19Y, MHCM floor - parquet polished wood |
|
|
| 5-19Y, MHCM floor - vinyl/asphalt strips |
|
|
| 5-19Y, MHCM floor - ceramic tiles |
|
|
| 5-19Y, MHCM floor - cement |
|
|
| 5-19Y, MHCM floor - carpet |
|
|
| 20+Y, MHCM walls - mud |
|
|
| 20+Y, MHCM walls - brick |
|
|
| 20+Y, MHCM walls - cement/plaster |
|
|
| 20+Y, MHCM walls - cement/paint |
|
|
| 20+Y, MHCM walls - other |
|
|
| 20+Y, MHCM floor - natural floor |
|
|
| 20+Y, MHCM floor - rudimentary floor |
|
|
| 20+Y, MHCM floor - parquet polished wood |
|
|
| 20+Y, MHCM floor - vinyl/asphalt strips |
|
|
| 20+Y, MHCM floor - ceramic tiles |
|
|
| 20+Y, MHCM floor - cement |
|
|
| 20+Y, MHCM floor - carpet |
|
|
|
| 6M-4Y, MHCM walls - brick |
|
|
| 6M-4Y, MHCM walls - cement/plaster |
|
|
| 6M-4Y, MHCM walls - cement/paint |
|
|
| 6M-4Y, MHCM walls - other |
|
|
| 6M-4Y, MHCM floor - natural floor |
|
|
| 6M-4Y, MHCM floor - rudimentary floor |
|
|
| 6M-4Y, MHCM floor - ceramic tiles |
|
|
| 6M-4Y, MHCM floor - cement |
|
|
| 6M-4Y, MHCM floor - carpet |
|
|
| 5-19Y, MHCM walls - mud |
|
|
| 5-19Y, MHCM walls - brick |
|
|
| 5-19Y, MHCM walls - cement/plaster |
|
|
| 5-19Y, MHCM walls - cement/paint |
|
|
| 5-19Y, MHCM walls - other |
|
|
| 5-19Y, MHCM floor - natural floor |
|
|
| 5-19Y, MHCM floor - rudimentary floor |
|
|
| 5-19Y, MHCM floor - ceramic tiles |
|
|
| 5-19Y, MHCM floor - cement |
|
|
| 5-19Y, MHCM floor - carpet |
|
|
| 20+Y, MHCM walls - mud |
|
|
| 20+Y, MHCM walls - brick |
|
|
| 20+Y, MHCM walls - cement/plaster |
|
|
| 20+Y, MHCM walls - cement/paint |
|
|
| 20+Y, MHCM walls - other |
|
|
| 20+Y, MHCM floor - natural floor |
|
|
| 20+Y, MHCM floor - rudimentary floor |
|
|
| 20+Y, MHCM floor - ceramic tiles |
|
|
| 20+Y, MHCM floor - cement |
|
|
| 20+Y, MHCM floor - carpet |
|
|
|
| 6M-4Y, MHCM walls - brick |
|
|
| 6M-4Y, MHCM walls - cement/plaster |
|
|
| 6M-4Y, MHCM walls - cement/paint |
|
|
| 6M-4Y, MHCM walls - other |
|
|
| 6M-4Y, MHCM floor - natural floor |
|
|
| 6M-4Y, MHCM floor - rudimentary floor |
|
|
| 6M-4Y, MHCM floor - vinyl/asphalt strips |
|
|
| 6M-4Y, MHCM floor - ceramic tiles |
|
|
| 6M-4Y, MHCM floor - cement |
|
|
| 6M-4Y, MHCM floor - carpet |
|
|
| 5-19Y, MHCM walls - mud |
|
|
| 5-19Y, MHCM walls - brick |
|
|
| 5-19Y, MHCM walls - cement/plaster |
|
|
| 5-19Y, MHCM walls - cement/paint |
|
|
| 5-19Y, MHCM walls - other |
|
|
| 5-19Y, MHCM floor - natural floor |
|
|
| 5-19Y, MHCM floor - rudimentary floor |
|
|
| 5-19Y, MHCM floor - vinyl/asphalt strips |
|
|
| 5-19Y, MHCM floor - ceramic tiles |
|
|
| 5-19Y, MHCM floor - cement |
|
|
| 5-19Y, MHCM floor - carpet |
|
|
| 20+Y, MHCM walls - mud |
|
|
| 20+Y, MHCM walls - brick |
|
|
| 20+Y, MHCM walls - cement/plaster |
|
|
| 20+Y, MHCM walls - cement/paint |
|
|
| 20+Y, MHCM walls - other |
|
|
| 20+Y, MHCM floor - natural floor |
|
|
| 20+Y, MHCM floor - rudimentary floor |
|
|
| 20+Y, MHCM floor - vinyl/asphalt strips |
|
|
| 20+Y, MHCM floor - ceramic tiles |
|
|
| 20+Y, MHCM floor - cement |
|
|
| 20+Y, MHCM floor - carpet |
|
|
|
| 6M-4Y, MHCM roof - iron sheet |
|
|
| 6M-4Y, MHCM roof - tiles |
|
|
| 6M-4Y, MHCM roof - other |
|
|
| 6M-4Y, MHCM windows/eaves - closed |
|
|
| 6M-4Y, MHCM windows/eaves - open |
|
|
| 6M-4Y, MHCM windows/eaves - partially open |
|
|
| 6M-4Y, MHCM windows/eaves - missing |
|
|
| 6M-4Y, MHCM, nets - not present |
|
|
| 6M-4Y, MHCM, nets - present on all windows |
|
|
| 6M-4Y, MHCM, nets - present on some windows |
|
|
| 5-19Y, MHCM roof - grass/palm |
|
|
| 5-19Y, MHCM roof - iron sheet |
|
|
| 5-19Y, MHCM roof - tiles |
|
|
| 5-19Y, MHCM roof - other |
|
|
| 5-19Y, MHCM roof - missing |
|
|
| 5-19Y, MHCM windows/eaves - closed |
|
|
| 5-19Y, MHCM windows/eaves - open |
|
|
| 5-19Y, MHCM windows/eaves - partially open |
|
|
| 5-19Y, MHCM windows/eaves - missing |
|
|
| 5-19Y, MHCM, nets - not present |
|
|
| 5-19Y, MHCM, nets - present on all windows |
|
|
| 5-19Y, MHCM, nets - present on some windows |
|
|
| 5-19Y, MHCM, nets - missing |
|
|
| 20+Y, MHCM roof - grass/palm |
|
|
| 20+Y, MHCM roof - iron sheet |
|
|
| 20+Y, MHCM roof - tiles |
|
|
| 20+Y, MHCM roof - other |
|
|
| 20+Y, MHCM roof - missing |
|
|
| 20+Y, MHCM windows/eaves - closed |
|
|
| 20+Y, MHCM windows/eaves - open |
|
|
| 20+Y, MHCM windows/eaves - partially open |
|
|
| 20+Y, MHCM windows/eaves - missing |
|
|
| 20+Y, MHCM, nets - not present |
|
|
| 20+Y, MHCM, nets - present on all windows |
|
|
| 20+Y, MHCM, nets - present on some windows |
|
|
| 20+Y, MHCM, nets - missing |
|
|
|
| 6M-4Y, MHCM roof - iron sheet |
|
|
| 6M-4Y, MHCM roof - tiles |
|
|
| 6M-4Y, MHCM roof - other |
|
|
| 6M-4Y, MHCM windows/eaves - closed |
|
|
| 6M-4Y, MHCM windows/eaves - open |
|
|
| 6M-4Y, MHCM windows/eaves - partially open |
|
|
| 6M-4Y, MHCM, nets - not present |
|
|
| 6M-4Y, MHCM, nets - present on all windows |
|
|
| 6M-4Y, MHCM, nets - present on some windows |
|
|
| 5-19Y, MHCM roof - grass/palm |
|
|
| 5-19Y, MHCM roof - iron sheet |
|
|
| 5-19Y, MHCM roof - tiles |
|
|
| 5-19Y, MHCM roof - other |
|
|
| 5-19Y, MHCM windows/eaves - closed |
|
|
| 5-19Y, MHCM windows/eaves - open |
|
|
| 5-19Y, MHCM windows/eaves - partially open |
|
|
| 5-19Y, MHCM, nets - not present |
|
|
| 5-19Y, MHCM, nets - present on all windows |
|
|
| 5-19Y, MHCM, nets - present on some windows |
|
|
| 20+Y, MHCM roof - grass/palm |
|
|
| 20+Y, MHCM roof - iron sheet |
|
|
| 20+Y, MHCM roof - tiles |
|
|
| 20+Y, MHCM roof - other |
|
|
| 20+Y, MHCM windows/eaves - closed |
|
|
| 20+Y, MHCM windows/eaves - open |
|
|
| 20+Y, MHCM windows/eaves - partially open |
|
|
| 20+Y, MHCM, nets - not present |
|
|
| 20+Y, MHCM, nets - present on all windows |
|
|
| 20+Y, MHCM, nets - present on some windows |
|
|
|
| 6M-4Y, MHCM roof - iron sheet |
|
|
| 6M-4Y, MHCM roof - tiles |
|
|
| 6M-4Y, MHCM roof - other |
|
|
| 6M-4Y, MHCM windows/eaves - closed |
|
|
| 6M-4Y, MHCM windows/eaves - open |
|
|
| 6M-4Y, MHCM windows/eaves - partially open |
|
|
| 6M-4Y, MHCM, nets - not present |
|
|
| 6M-4Y, MHCM, nets - present on all windows |
|
|
| 6M-4Y, MHCM, nets - present on some windows |
|
|
| 5-19Y, MHCM roof - grass/palm |
|
|
| 5-19Y, MHCM roof - iron sheet |
|
|
| 5-19Y, MHCM roof - tiles |
|
|
| 5-19Y, MHCM roof - other |
|
|
| 5-19Y, MHCM windows/eaves - closed |
|
|
| 5-19Y, MHCM windows/eaves - open |
|
|
| 5-19Y, MHCM windows/eaves - partially open |
|
|
| 5-19Y, MHCM, nets - not present |
|
|
| 5-19Y, MHCM, nets - present on all windows |
|
|
| 5-19Y, MHCM, nets - present on some windows |
|
|
| 20+Y, MHCM roof - grass/palm |
|
|
| 20+Y, MHCM roof - iron sheet |
|
|
| 20+Y, MHCM roof - tiles |
|
|
| 20+Y, MHCM roof - other |
|
|
| 20+Y, MHCM windows/eaves - closed |
|
|
| 20+Y, MHCM windows/eaves - open |
|
|
| 20+Y, MHCM windows/eaves - partially open |
|
|
| 20+Y, MHCM, nets - not present |
|
|
| 20+Y, MHCM, nets - present on all windows |
|
|
| 20+Y, MHCM, nets - present on some windows |
|
|
|
| 6M-4Y, MHCM roof - iron sheet |
|
|
| 6M-4Y, MHCM roof - other |
|
|
| 6M-4Y, MHCM windows/eaves - closed |
|
|
| 6M-4Y, MHCM windows/eaves - open |
|
|
| 6M-4Y, MHCM windows/eaves - partially open |
|
|
| 6M-4Y, MHCM, nets - not present |
|
|
| 6M-4Y, MHCM, nets - present on all windows |
|
|
| 6M-4Y, MHCM, nets - present on some windows |
|
|
| 5-19Y, MHCM roof - grass/palm |
|
|
| 5-19Y, MHCM roof - iron sheet |
|
|
| 5-19Y, MHCM roof - other |
|
|
| 5-19Y, MHCM windows/eaves - closed |
|
|
| 5-19Y, MHCM windows/eaves - open |
|
|
| 5-19Y, MHCM windows/eaves - partially open |
|
|
| 5-19Y, MHCM, nets - not present |
|
|
| 5-19Y, MHCM, nets - present on all windows |
|
|
| 5-19Y, MHCM, nets - present on some windows |
|
|
| 20+Y, MHCM roof - grass/palm |
|
|
| 20+Y, MHCM roof - iron sheet |
|
|
| 20+Y, MHCM roof - other |
|
|
| 20+Y, MHCM windows/eaves - closed |
|
|
| 20+Y, MHCM windows/eaves - open |
|
|
| 20+Y, MHCM windows/eaves - partially open |
|
|
| 20+Y, MHCM, nets - not present |
|
|
| 20+Y, MHCM, nets - present on all windows |
|
|
| 20+Y, MHCM, nets - present on some windows |
|
|
|
| 6M-4Y, MSDW - closed water source |
|
|
| 6M-4Y, MSDW - open water source |
|
|
| 6M-4Y, PE - Yes |
|
|
| 6M-4Y, PE - No |
|
|
| 5-19Y, MSDW - bottled water |
|
|
| 5-19Y, MSDW - closed water source |
|
|
| 5-19Y, MSDW - open water source |
|
|
| 5-19Y, MSDW - missing |
|
|
| 5-19Y, PE - Yes |
|
|
| 5-19Y, PE - No |
|
|
| 5-19Y, PE - missing |
|
|
| 20+Y, MSDW - bottled water |
|
|
| 20+Y, MSDW - closed water source |
|
|
| 20+Y, MSDW - open water source |
|
|
| 20+Y, MSDW - missing |
|
|
| 20+Y, PE - Yes |
|
|
| 20+Y, PE - No |
|
|
| 20+Y, PE - missing |
|
|
|
| 6M-4Y, MSDW - closed water source |
|
|
| 6M-4Y, MSDW - open water source |
|
|
| 6M-4Y, PE - Yes |
|
|
| 6M-4Y, PE - No |
|
|
| 5-19Y, MSDW - bottled water |
|
|
| 5-19Y, MSDW - closed water source |
|
|
| 5-19Y, MSDW - open water source |
|
|
| 5-19Y, PE - Yes |
|
|
| 5-19Y, PE - No |
|
|
| 20+Y, MSDW - bottled water |
|
|
| 20+Y, MSDW - closed water source |
|
|
| 20+Y, MSDW - open water source |
|
|
| 20+Y, PE - Yes |
|
|
| 20+Y, PE - No |
|
|
|
| 6M-4Y, MSDW - closed water source |
|
|
| 6M-4Y, MSDW - open water source |
|
|
| 6M-4Y, PE - Yes |
|
|
| 6M-4Y, PE - No |
|
|
| 5-19Y, MSDW - bottled water |
|
|
| 5-19Y, MSDW - closed water source |
|
|
| 5-19Y, MSDW - open water source |
|
|
| 5-19Y, PE - Yes |
|
|
| 5-19Y, PE - No |
|
|
| 20+Y, MSDW - bottled water |
|
|
| 20+Y, MSDW - closed water source |
|
|
| 20+Y, MSDW - open water source |
|
|
| 20+Y, PE - Yes |
|
|
| 20+Y, PE - No |
|
|
|
| 6M-4Y, MSDW - closed water source |
|
|
| 6M-4Y, MSDW - open water source |
|
|
| 6M-4Y, PE - Yes |
|
|
| 6M-4Y, PE - No |
|
|
| 5-19Y, MSDW - bottled water |
|
|
| 5-19Y, MSDW - closed water source |
|
|
| 5-19Y, MSDW - open water source |
|
|
| 5-19Y, PE - Yes |
|
|
| 5-19Y, PE - No |
|
|
| 20+Y, MSDW - bottled water |
|
|
| 20+Y, MSDW - closed water source |
|
|
| 20+Y, MSDW - open water source |
|
|
| 20+Y, PE - Yes |
|
|
| 20+Y, PE - No |
|
|
|
| [6M-4Y], UMc > 7D, Missing/No |
|
|
| [6M-4Y], UIs > 7D, Yes |
|
|
| [6M-4Y], UIs > 7D, Missing/No |
|
|
| [6M-4Y], UCR > 7D, Yes |
|
|
| [6M-4Y], UCR > 7D, Missing/No |
|
|
| [6M-4Y], UTR > 7D, Yes |
|
|
| [6M-4Y], UTR > 7D, Missing/No |
|
|
| [6M-4Y], Una >7D, Yes |
|
|
| [6M-4Y], Una >7D, Missing/No |
|
|
| [6M-4Y], Uirs past 12M, Yes |
|
|
| [6M-4Y], Uirs past 12M, Missing/No |
|
|
| [6M-4Y], Uirs-nM [1 Month] |
|
|
| [6M-4Y], Uirs-nM [11 Months] |
|
|
| [6M-4Y], Uirs-nM [12 Months] |
|
|
| [6M-4Y], Uirs-nM [10 Months] |
|
|
| [6M-4Y], Uirs-nM [2 Months] |
|
|
| [6M-4Y], Uirs-nM [3 Months] |
|
|
| [6M-4Y], Uirs-nM [4 Months] |
|
|
| [6M-4Y], Uirs-nM [5 Months] |
|
|
| [6M-4Y], Uirs-nM [6 Months] |
|
|
| [6M-4Y], Uirs-nM [7 Months] |
|
|
| [6M-4Y], Uirs-nM [9 Months] |
|
|
| [6M-4Y], Uirs-nM [no spray] |
|
|
| [5-19Y], UMc > 7D, Yes |
|
|
| [5-19Y], UMc > 7D, Missing/No |
|
|
| [5-19Y], UIs > 7D, Yes |
|
|
| [5-19Y], UIs > 7D, Missing/No |
|
|
| [5-19Y], UCR > 7D, Yes |
|
|
| [5-19Y], UCR > 7D, Missing/No |
|
|
| [5-19Y], UTR > 7D, Yes |
|
|
| [5-19Y], UTR > 7D, Missing/No |
|
|
| [5-19Y], Una >7D, Yes |
|
|
| [5-19Y], Una >7D, Missing/No |
|
|
| [5-19Y], Uirs past 12M, Yes |
|
|
| [5-19Y], Uirs past 12M, Missing/No |
|
|
| [5-19Y], Uirs-nM [1 Month] |
|
|
| [5-19Y], Uirs-nM [11 Months] |
|
|
| [5-19Y], Uirs-nM [12 Months] |
|
|
| [5-19Y], Uirs-nM [10 Months] |
|
| [5-19Y], Uirs-nM [2 Months] |
|
|
| [5-19Y], Uirs-nM [3 Months] |
|
|
| [5-19Y], Uirs-nM [4 Months] |
|
|
| [5-19Y], Uirs-nM [5 Months] |
|
|
| [5-19Y], Uirs-nM [6 Months] |
|
|
| [5-19Y], Uirs-nM [7 Months] |
|
|
| [5-19Y], Uirs-nM [9 Months] |
|
|
| [5-19Y], Uirs-nM [no spray] |
|
|
| [Y20+], UMc > 7D, Yes |
|
|
| [Y20+], UMc > 7D, Missing/No |
|
|
| [Y20+], UIs > 7D, Yes |
|
|
| [Y20+], UIs > 7D, Missing/No |
|
|
| [Y20+], UCR > 7D, Yes |
|
|
| [Y20+], UCR > 7D, Missing/No |
|
|
| [Y20+], UTR > 7D, Yes |
|
|
| [Y20+], UTR > 7D, Missing/No |
|
|
| [Y20+], Una >7D, Yes |
|
|
| [Y20+], Una >7D, Missing/No |
|
|
| [Y20+], Uirs past 12M, Yes |
|
|
| [Y20+], Uirs past 12M, Missing/No |
|
|
| [Y20+], Uirs-nM [1 Month] |
|
|
| [Y20+], Uirs-nM [11 Months] |
|
|
| [Y20+], Uirs-nM [12 Months] |
|
|
| [Y20+], Uirs-nM [10 Months] |
|
|
| [Y20+], Uirs-nM [2 Months] |
|
|
| [Y20+], Uirs-nM [3 Months] |
|
|
| [Y20+], Uirs-nM [4 Months] |
|
|
| [Y20+], Uirs-nM [5 Months] |
|
|
| [Y20+], Uirs-nM [6 Months] |
|
|
| [Y20+], Uirs-nM [7 Months] |
|
|
| [Y20+], Uirs-nM [9 Months] |
|
|
| [Y20+], Uirs-nM [no spray] |
|
|
| Title | Measurements |
|---|---|
|
| P.Vivax, Pos |
|
| P.Vivax, Neg |
|
| P.Ovale, Pos |
|
| P.Ovale, Neg |
|
| Title | Measurements |
|---|---|
|
| P.Vivax, Pos |
|
| P.Vivax, Neg |
|
| P.Ovale, Pos |
|
| P.Ovale, Neg |
|
| Title | Measurements |
|---|---|
|
| P.Vivax, Pos |
|
| P.Vivax, Neg |
|
| P.Ovale, Pos |
|
| P.Ovale, Neg |
|
| Title | Measurements |
|---|---|
|
| P.Vivax, Pos |
|
| P.Vivax, Neg |
|
| P.Ovale, Pos |
|
| P.Ovale, Neg |
|